Commercialisation of cell and gene therapies: What does it take
Tracks
Track 3
| Friday, November 1, 2024 |
| 12:35 PM - 1:20 PM |
Details
To successfully deliver new cell and gene therapies to patients, companies first need to travel the ups and downs of commercialisation. Cell and gene entrepreneurs and CEOs will present short, sharp pitch-style talks about how they have steered their company toward success. In the conversation to follow, they will discuss how they navigated different challenges on their startup to scaleup journey and what strategies they developed to ensure they could progress their technology to market.
Speaker
Sam Cobb
Chief Executive Officer
Currus
Panellist
Daniel Getts
Chief Executive Officer
Myeloid Therapeutics
Panellist
